EDMOND DE ROTHSCHILD HOLDING S.A.
Position in NRIX — Nurix Therapeutics, Inc.
CIK 1649647
Chambesy, V8
Position in NRIX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,183,400
+$788,400 QoQ
Shares Held
90,000
0.0% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#85
of 210 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EDMOND DE ROTHSCHILD HOLDING S.A. holds $84,636,966 across 13 Biotechnology names. NRIX ranks #8 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
687,030 | $39,311,856 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
33,660 | $9,592,090 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
113,320 | $8,985,142 | |
| 4 | BNTX |
BioNTech SE
|
92,310 | $8,589,445 | |
| 5 | MRNA |
Moderna, Inc.
|
70,747 | $4,954,411 | |
| 6 | DNLI |
Denali Therapeutics Inc.
|
165,080 | $4,245,857 | |
| 7 | GERN |
Geron Corp
|
2,330,000 | $2,982,400 | |
| 8 | NRIX |
Nurix Therapeutics, Inc.
This page
|
90,000 | $2,183,400 |
All Filings in NRIX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,183,400 | 90,000 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,395,000 | 90,000 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,517,600 | 80,000 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||